Stay updated on Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page
- Check4 days agoChange DetectedThe page's revision tag was updated to v3.6.3, replacing the previous v3.6.2.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a maintenance update to the site software rather than changes to visible content. This update does not alter the information presented or how users interact with the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now indicates that recruitment has ended for this study. Additional navigation and help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and minor formatting/version updates were applied.SummaryDifference0.4%

- Check33 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the page, indicating a minor backend/template update. There are no visible changes to the study details or user-facing content.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.5.4 and removed Revision: v3.5.3, indicating an update to the page's version label. This appears to be a metadata/UI update rather than a change to the study content.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page revision tag updated to v3.5.3 from v3.5.2. This reflects a minor update to the record and does not affect the study data.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.